Inspire Medical Systems, Inc.·4

May 11, 4:05 PM ET

mcCormick Shawn 4

4 · Inspire Medical Systems, Inc. · Filed May 11, 2026

Research Summary

AI-generated summary of this filing

Updated

Inspire Medical (INSP) Director Shawn McCormick Sells 696 Shares

What Happened
Shawn McCormick, a director of Inspire Medical Systems, sold 696 shares in an open-market transaction on May 8, 2026. The shares were sold at $45.31 each for a total of approximately $31,536. This was a sale (not a purchase or option exercise).

Key Details

  • Transaction date: 2026-05-08 (reported on Form 4 filed 2026-05-11, Accession 0001104659-26-058634)
  • Transaction type/code: Open-market sale (S)
  • Price per share: $45.31
  • Shares sold: 696
  • Transaction value: ~$31,536
  • Shares owned after transaction: Not specified in the provided filing
  • Footnote: All sales were made pursuant to a Rule 10b5-1 trading plan dated August 29, 2025
  • Timeliness: Filing appears timely (transaction 5/8/2026; Form 4 filed 5/11/2026)

Context
Sales executed under a pre-established Rule 10b5-1 plan are typically scheduled in advance and do not necessarily indicate the insider’s current view of the company. The sale amount here is modest relative to typical executive trades; retail investors should view this as routine insider activity rather than a clear signal of company performance.

Insider Transaction Report

Form 4
Period: 2026-05-08
Transactions
  • Sale

    Common Stock

    2026-05-08$45.31/sh696$31,53627,712 total
Holdings
  • Common Stock

    (indirect: By Trust)
    3,000
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Shawn T McCormick|2026-05-11

Documents

1 file
  • 4
    tm2614263-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT